Dystrobrevin and Desmin
Total Page:16
File Type:pdf, Size:1020Kb
Desmuslin, an intermediate filament protein that interacts with ␣-dystrobrevin and desmin Yuji Mizuno*, Terri G. Thompson*, Jeffrey R. Guyon*, Hart G. W. Lidov*, Melissa Brosius*, Michihiro Imamura†, Eijiro Ozawa†, Simon C. Watkins‡, and Louis M. Kunkel*§ *Howard Hughes Medical Institute͞Division of Genetics, Children’s Hospital and Harvard Medical School, Boston, MA 02115; †National Institute of Neuroscience, National Center for Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan; and ‡Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA 15261 Contributed by Louis M. Kunkel, March 28, 2001 Dystrobrevin is a component of the dystrophin-associated protein (19), the rabbit 94-kDa protein (A0) (20), and -dystrobrevin complex and has been shown to interact directly with dystrophin, (21). ␣-Dystrobrevin 1 has a unique C-terminal region with ␣1-syntrophin, and the sarcoglycan complex. The precise role of multiple sites for tyrosine phosphorylation and is highly ex- ␣-dystrobrevin in skeletal muscle has not yet been determined. To pressed in muscle and brain. This protein has two predicted study ␣-dystrobrevin’s function in skeletal muscle, we used the ␣-helical coiled-coil motifs and has been shown to interact yeast two-hybrid approach to look for interacting proteins. Three directly with ␣1-syntrophin (16, 17) and dystrophin (12). The overlapping clones were identified that encoded an intermediate ␣-dystrobrevin 2 splice form is slightly different in that it lacks filament protein we subsequently named desmuslin (DMN). Se- the unique C-terminal region and thus would not be phosphor- quence analysis revealed that DMN has a short N-terminal domain, ylated. ␣-Dystrobrevin 3 has an alternatively spliced 3Ј end that a conserved rod domain, and a long C-terminal domain, all common is more truncated than that of ␣-dystrobrevin 2. ␣-Dystrobrevin features of type 6 intermediate filament proteins. A positive 4 and 5 have a different 5Ј start site relative to variants 1–3. interaction between DMN and ␣-dystrobrevin was confirmed with To better understand the role of ␣-dystrobrevin in skeletal an in vitro coimmunoprecipitation assay. By Northern blot analysis, muscle, we looked for interacting proteins by using the yeast we find that DMN is expressed mainly in heart and skeletal muscle, two-hybrid technique. We isolated three overlapping clones and although there is some expression in brain. Western blotting confirmed their interaction with dystrobrevin with in vitro co- detected a 160-kDa protein in heart and skeletal muscle. Immuno- immunoprecipitation (CoIP). A full-length cDNA clone of the fluorescent microscopy localizes DMN in a stripe-like pattern in interacting protein was isolated. This protein, desmuslin (DMN), longitudinal sections and in a mosaic pattern in cross sections of colocalizes to the Z-lines with desmin. Our results suggest that skeletal muscle. Electron microscopic analysis shows DMN colocal- DMN forms a linkage between desmin and extracellular matrix ized with desmin at the Z-lines. Subsequent coimmunoprecipita- and therefore provides an important structural support in tion experiments confirmed an interaction with desmin. Our find- muscle. ings suggest that DMN may serve as a direct linkage between the extracellular matrix and the Z-discs (through plectin) and may play Materials and Methods an important role in maintaining muscle cell integrity. Yeast Two-Hybrid Library Screening. ␣-Dystrobrevin cDNA (nucle- otides 7–1617) was inserted downstream of the Gal-4 DNA- he severe muscle wasting disorder, Duchenne muscular binding domain in the pGBT9 bait vector. A yeast two-hybrid Tdystrophy, is caused by abnormalities in the dystrophin gene cDNA library derived from human skeletal muscle was screened (1). The dystrophin protein is expressed in heart and skeletal for interacting proteins with the use of the Matchmaker two- muscle, where it is part of the dystrophin-associated protein hybrid system as described by the distributor (CLONTECH). complex. Dystrophin’s N-terminal domain binds to actin, In brief, transformation mixtures were spread on synthetic whereas the WW domain and the total cysteine-rich domain bind dropout͞ϪHis͞ϪLeu͞ϪTrp͞ϩ3-amino-1,2,4-triazole plates to -dystroglycan (2), a component of the dystroglycan subcom- and incubated at 30°C until colonies appeared (6 days). Colonies plex. This subcomplex links to laminin, a major component of the able to grow on minimal plates were screened for -galactosidase basal membrane, thereby forming the linkage between an intra- activity with the use of a filter-lift assay as described by the cellular protein, actin, and the extracellular matrix. manufacturer. Yeast DNA isolated from colonies positive for A second subcomplex of the dystrophin-associated protein -galactosidase activity was used to electroporate Escherichia complex includes four transmembrane proteins (␣-, -, ␥-, and coli to recover the interacting cDNA. The sequence of the ␦-sarcoglycan) (3). Each has been shown to be involved in interacting cDNA was analyzed on an ABI 373 or 377 automated different forms of limb-girdle muscular dystrophy (LGMD 2D, sequencer with the use of fluorescent dye terminator chemistry 2E, 2C, and 2F) (4–8). ␣-Sarcoglycan is a type 1 transmembrane (Applied Biosystems). protein and is expressed in heart and skeletal muscle. -, ␥-, and ␦-sarcoglycans are type 2 transmembrane proteins containing a Phage cDNA Library Screening. A gt 11 human skeletal muscle cluster of cysteine residues in their extracellular domains. These library (CLONTECH) was screened with a 152-bp hybridization four proteins form the sarcoglycan complex, which is thought to probe homologous to DMN’s 5Ј region (Fig. 2A, nucleotides Ϫ23 be involved in some type of signaling pathway (9). A third subcomplex of the dystrophin-associated protein complex involves ␣-dystrobrevin (10–12) and the syntrophins Abbreviations: CoIP, coimmunoprecipitation; DMN, desmuslin; IF, intermediate filament. (␣1, 1, and 2) (13–15). These intracellular proteins directly Data deposition: The sequence reported in this paper has been deposited in the GenBank bind to dystrophin (16, 17). In addition, the N-terminal region of database (accession no. AF359284). ␣-dystrobrevin associates with the sarcoglycan complex (18). §To whom reprint requests should be addressed at: Howard Hughes Medical Institute, Division of Genetics, Enders 570, Children’s Hospital, 300 Longwood Avenue, Boston, MA There are at least five different forms of ␣-dystrobrevin gener- ␣ 02115. E-mail: [email protected]. ated by alternative splicing. The largest splice variant -dystro- The publication costs of this article were defrayed in part by page charge payment. This brevin 1 shows sequence homology to the cysteine-rich and article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. C-terminal domains of dystrophin, the Torpedo 87-kDa protein §1734 solely to indicate this fact. 6156–6161 ͉ PNAS ͉ May 22, 2001 ͉ vol. 98 ͉ no. 11 www.pnas.org͞cgi͞doi͞10.1073͞pnas.111153298 Downloaded by guest on September 26, 2021 of the subcloned cDNAs also was expressed from the pFHR2 vector along with the rest of the protein. Proteins expressed from these vectors were termed FLAG 4C, FLAG 5D-1, or FLAG 5D-2 (Fig. 1B). We also made several truncated versions of DMN to identify the subregion that interacted with ␣-dystrobrevin. Constructs were prepared by PCR amplification, using full-length DMN as the template. The DMN PCR product covered the sequence from Ϫ3 to 1011 and was subcloned into pFHR2 to express FLAG 1A-1B-2A-2B (amino acids Ϫ1 to 337). Constructs 1A-1B-2A (amino acids Ϫ1 to 225), 2A-2B (amino acids 161– 337), 1B-2A (amino acids 62–225), C-terminal-1 (amino acids 336–933), and C-terminal-2 (amino acids 932-1253) were cloned in a similar fashion. Clone 4C inserted into pFHR2 was used to express FLAG 1A-1B (amino acids Ϫ34 to 153). Desmin was cloned by PCR amplification from total cellular RNA isolated from human skeletal muscle (CLONTECH). The Fig. 1. CoIP analysis of DMN clones with dystrobrevin. (A) Alignment of PCR product was subcloned into pMGT1 and sequenced. KIAA0353 (22) and DMN clones 4C, 5D, 5D-1, and 5D-2. IF designates a region with an intermediate filament signature. (B) When simultaneously expressed, Antibodies. Synthetic peptides corresponding to DMN-1 amino FLAG 5D-1 coimmunoprecipitates dystrobrevin (compare lane 5 to lane 4). FLAG 5D-2 and FLAG 4C do not coimmunoprecipitate dystrobrevin (lanes 6 acids 232–250 (C-QEAEALRREALGLEQLRAR) and and 7). Our controls show that the FLAG antibody specifically precipitates DMN-2 amino acids 1038–1053 (C-SLSRQRSPAPGSPDEE) proteins with the FLAG epitope (lanes 1–3) and precipitates background levels (Fig. 2A) were generated and used to inject New Zealand White of dystrobrevin (lane 4). * indicates 35S-labeled dystrobrevin. ϩ͞Ϫ indicates rabbits (Research Genetics, Huntsville, AL). The amino- the presence or absence of a particular construct. terminal cysteine is not part of the DMN sequence, but was added for subsequent affinity purification with the use of a SulfoLink coupling gel (Pierce). Anti-FLAG mAb was pur- to 129). The probe was labeled with the use of a Random Primer chased from Sigma. DNA Labeling System (GIBCO͞BRL) in the presence of 5 Ci of [␣-32P]dCTP. Filters were prehybridized in hybridization In Vitro Transcription͞Translation and CoIP. Proteins encoding the buffer [5ϫ SSC (0.75 M NaCl͞0.075 M sodium citrate)͞50 mM various constructs were labeled with [35S]methionine with a TNT sodium phosphate (pH 7.4)͞1ϫ Denhardt’s solution (0.02% Quick Coupled Transcription͞Translation System (Promega). Ficoll [type 400]͞0.02% polyvinylpyrrolidone͞0.02% BSA)] for Depending on the experiment, the proteins were expressed 5.5 h at 65°C. The denatured probe (8.9 ϫ 105 cpm͞ml) was either individually or simultaneously. Five microliters of protein added to the hybridization buffer, and the filters were hybridized lysate was added to 25 l of CoIP buffer [150 mM NaCl͞50 mM for 18 h at 65°C. Filters were washed in 2ϫ SSC and 0.1% SDS Tris⅐HCl (pH 7.4)͞1% Nonidet P-40͞Protease Inhibitor Mixture for 30 min at 55°C with several changes of washing solution.